TGFβ


Journal

Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479

Informations de publication

Date de publication:
12 2022
Historique:
revised: 03 11 2022
received: 09 06 2022
accepted: 07 12 2022
entrez: 20 12 2022
pubmed: 21 12 2022
medline: 22 12 2022
Statut: ppublish

Résumé

Transforming growth factor β (TGFβ) is a major component of tumor-derived small extracellular vesicles (TEX) in cancer patients. Mechanisms utilized by TGFβ

Identifiants

pubmed: 36537293
doi: 10.1002/jev2.12294
pmc: PMC9764108
doi:

Substances chimiques

Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12294

Subventions

Organisme : NIH HHS
ID : U01-DE-029759
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE031299
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA168628
Pays : United States
Organisme : NIDCR NIH HHS
ID : U01 DE029759
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009615
Pays : United States
Organisme : NIH HHS
ID : R01-CA 168628
Pays : United States

Informations de copyright

© 2022 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.

Références

Cancers (Basel). 2021 Aug 31;13(17):
pubmed: 34503207
Front Oncol. 2018 Oct 12;8:445
pubmed: 30370252
J Exp Clin Cancer Res. 2018 Jul 9;37(1):143
pubmed: 29986759
Front Oral Health. 2021 Dec 15;2:816963
pubmed: 35048080
Cancers (Basel). 2021 Aug 19;13(16):
pubmed: 34439329
Nature. 2021 Sep;597(7875):279-284
pubmed: 34471285
Front Oncol. 2021 Jun 14;11:683570
pubmed: 34195084
Cancer Immunol Immunother. 2021 Apr;70(4):1015-1029
pubmed: 33104837
Adv Clin Chem. 2016;74:103-41
pubmed: 27117662
Cancer Res. 2018 Mar 1;78(5):1225-1240
pubmed: 29259013
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Cancer Lett. 2020 May 28;478:34-44
pubmed: 32120025
Cell Commun Signal. 2022 Jan 28;20(1):12
pubmed: 35090495
Cancer Res. 1991 Feb 15;51(4):1339-44
pubmed: 1705173
J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
Anal Chim Acta. 2012 Apr 20;723:61-7
pubmed: 22444574
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Cancer Res. 2010 Dec 1;70(23):9621-30
pubmed: 21098712
J Extracell Vesicles. 2020 May 31;9(1):1769373
pubmed: 33144925
Front Immunol. 2014 Apr 10;5:160
pubmed: 24782865
JCI Insight. 2019 Dec 5;4(23):
pubmed: 31661464
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Mol Cancer Res. 2018 Nov;16(11):1798-1808
pubmed: 30042174
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Carcinogenesis. 2020 Jul 10;41(5):625-633
pubmed: 31245809
Mol Cancer Ther. 2021 Jun;20(6):1102-1111
pubmed: 33850003
J Extracell Vesicles. 2018 Feb 15;7(1):1435138
pubmed: 29511460
J Extracell Vesicles. 2022 Dec;11(12):e12294
pubmed: 36537293
Oncoimmunology. 2019 Apr 15;8(7):1593808
pubmed: 31143515
J Biol Chem. 2017 Apr 28;292(17):7173-7188
pubmed: 28228478
Immunity. 2019 Apr 16;50(4):924-940
pubmed: 30995507
BMC Syst Biol. 2014 May 15;8:55
pubmed: 24886091
BMC Cell Biol. 2006 Mar 20;7:15
pubmed: 16549026
Cancers Head Neck. 2020 Apr 6;5:5
pubmed: 32280512
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34599030
Cell Adh Migr. 2017 Mar 4;11(2):187-195
pubmed: 28129015
Immunity. 2020 Jan 14;52(1):183-199.e9
pubmed: 31924475
Commun Biol. 2019 Oct 18;2:386
pubmed: 31646189
Sci Rep. 2020 Jan 9;10(1):92
pubmed: 31919420
Curr Protoc Immunol. 2019 Dec;127(1):e91
pubmed: 31763776
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Clin Cancer Res. 2017 Aug 15;23(16):4843-4854
pubmed: 28400428
Oncotarget. 2016 Dec 27;7(52):86087-86102
pubmed: 27863384
J Biol Chem. 2014 Aug 8;289(32):22258-67
pubmed: 24951588
J Cell Biochem. 2016 Jun;117(6):1279-87
pubmed: 26774024
Cold Spring Harb Perspect Biol. 2016 May 02;8(5):
pubmed: 27141051
Clin Cancer Res. 2018 Jun 15;24(12):2780-2793
pubmed: 29549162
J Immunol. 1990 Jan 15;144(2):521-5
pubmed: 2153170
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34083421
EMBO J. 2022 Sep 15;41(18):e109288
pubmed: 36052513
Angiogenesis. 2020 Nov;23(4):599-610
pubmed: 32419057
Cancer Res. 1989 Sep 15;49(18):5167-75
pubmed: 2766286
Exp Cell Res. 2019 May 15;378(2):149-157
pubmed: 30857972
Science. 2019 Aug 9;365(6453):544-545
pubmed: 31395771
Expert Opin Ther Targets. 2018 May;22(5):409-417
pubmed: 29634426
Nat Rev Immunol. 2019 Jun;19(6):369-382
pubmed: 30718830
Nat Med. 2003 Jun;9(6):653-60
pubmed: 12778163
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Nils Ludwig (N)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.

Saigopalakrishna S Yerneni (SS)

Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.

Juliana H Azambuja (JH)

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
Postgraduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.

Monika Pietrowska (M)

Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.

Piotr Widłak (P)

Medical University of Gdańsk, Gdańsk, Poland.

Cynthia S Hinck (CS)

Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Alicja Głuszko (A)

Chair and Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland.

Mirosław J Szczepański (MJ)

Chair and Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland.
Department of Otolaryngology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Teresa Kärmer (T)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Isabella Kallinger (I)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Daniela Schulz (D)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Richard J Bauer (RJ)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Gerrit Spanier (G)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Steffen Spoerl (S)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Johannes K Meier (JK)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Tobias Ettl (T)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Beatrice M Razzo (BM)

Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.

Torsten E Reichert (TE)

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.

Andrew P Hinck (AP)

Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Theresa L Whiteside (TL)

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
Departments of Immunology and Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH